Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: J Immunol. 2013 Jun 10;191(2):650–659. doi: 10.4049/jimmunol.1300398

Figure 4. p38α signaling in CD103+ MLN DCs drives iTreg differentiation independently of IL-27, IL-6 and IL-12.

Figure 4

(A) Expression of IL-27 in CD103+ MLN DCs isolated from WT and p38αΔDC mice. (B) Expression of Foxp3 in OT-II T cells activated with WT or p38α-deficient CD103+ DCs, in the presence of OVA (0.05 μg/ml), with or without αIL-27for 5 days. (C) Foxp3 expression in OT-II T cells activated with CD103+ MLN DCs isolated from WT, p38αΔDC, Il6–/–, p38αΔDC Il6–/–, Il12a–/–, or p38αΔDC Il12a–/– mice, in the presence of OVA (0.05 μg/ml), for 5 days. Data are representative of 2 independent experiments (n=3 mice per group).

HHS Vulnerability Disclosure